Internal Medicine, Hematology & Oncology · Dorado, PR
NPI
1780978346
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
478 Camino de la Vega
Dorado, PR, 00646
Phone (787) 314-1909
Groups this clinician bills Medicare through
Medicare paid, 2023
$3,032
33 services
Medicare patients, 2023
17
Average age 76
Drug cost, 2024
$2.5M
746 prescriptions
Company payments, 2025
$2,586
From 24 companies
Medicare prescription drug claims, 2024
In 2024, the drug Solalba Bueno-Orengo prescribed most often to Medicare patients was Anastrozole, with 122 prescriptions and refills. In total Solalba Bueno-Orengo wrote 746 Medicare prescriptions that cost $2.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 122 | 142 | 20 | $1,805 |
| Hydroxyurea Generic | 85 | 93 | Under 11 | $3,035 |
| Lonsurf Trifluridine/Tipiracil Hcl | 54 | 54 | Under 11 | $550K |
| Eliquis Apixaban | 31 | 35 | Under 11 | $19K |
| Letrozole Generic | 28 | 30 | Under 11 | $305 |
| Ondansetron Hcl Generic | 25 | 25 | 15 | $226 |
| Revlimid Lenalidomide | 25 | 25 | Under 11 | $496K |
| Xtandi Enzalutamide | 25 | 25 | Under 11 | $356K |
| Prednisone Generic | 24 | 24 | Under 11 | $140 |
| Megestrol Acetate Generic | 23 | 23 | Under 11 | $510 |
| Xarelto Rivaroxaban | 22 | 26 | Under 11 | $15K |
| Retacrit Epoetin Alfa-Epbx | 21 | 27 | 15 | $13K |
| Famotidine Generic | 19 | 21 | Under 11 | $133 |
| Dexamethasone Generic | 18 | 18 | Under 11 | $322 |
| Tramadol Hcl Generic | 17 | 17 | Under 11 | $89.54 |
Brand drugs: 262 claims; generic drugs: 484 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Solalba Bueno-Orengo $2,586 ($2,586 in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Pharmaceuticals, Inc with $460.
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc JNJ | 20 | $460 |
| AstraZeneca Pharmaceuticals LP AZN | 17 | $401 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $300 |
| Pbg Puerto Rico LLC | 9 | $214 |
| Abbvie Inc. ABBV | 9 | $210 |
| Merck Sharp & Dohme LLC MRK | 6 | $121 |
| Amgen Inc. AMGN | 5 | $100 |
| Tempus AI, Inc TEM | 5 | $95.41 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 4 | $92.84 |
| Genentech USA, Inc. ROG.SW | 3 | $75.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.